Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity

Clinical Trial ID NCT02353455

Rank	Title	Journal	Year	PubWeight™‹?›
1	Drug-induced hepatotoxicity.	N Engl J Med	2003	7.11
2	Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.	Gastroenterology	2008	5.45
3	Drug-induced liver injury: summary of a single topic clinical research conference.	Hepatology	2006	2.24
4	Liver transplantation for acute liver failure from drug induced liver injury in the United States.	Liver Transpl	2004	1.96
5	Risk factors for idiosyncratic drug-induced liver injury.	Gastroenterology	2010	1.51
6	Recognizing drug-induced liver injury: current problems, possible solutions.	Toxicol Pathol	2005	1.45
7	Epidemiology of idiosyncratic drug-induced liver injury.	Semin Liver Dis	2009	1.10
8	Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation.	Hepatology	2010	0.95
9	Drug-induced liver disease.	Drugs	1978	0.82
10	Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.	Gut	2015	0.76
11	Human monocyte-derived cells with individual hepatocyte characteristics: a novel tool for personalized in vitro studies.	Lab Invest	2012	0.75